Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GUTSNASDAQ:ICADNASDAQ:LLITNASDAQ:MGRM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUTSFractyl Health$2.06-5.1%$1.61$0.87▼$6.18$100.89M1.85326,688 shs290,851 shsICADiCAD$3.68-2.1%$3.33$1.18▼$4.02$101.09M1.38420,611 shs154,926 shsLLITLianluo Smart$9.36-10.2%$9.91$2.76▼$17.14$20.70M0.161.04 million shs264,331 shsMGRMMonogram Orthopaedics$2.66+1.1%$2.65$1.92▼$4.21$94.93M0.42248,406 shs46,058 shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUTSFractyl Health-5.07%+3.52%+34.20%+60.94%-66.23%ICADiCAD-2.13%-5.64%-5.88%+60.70%+138.96%LLITLianluo Smart-2.71%-1.04%+100.38%+3,620.10%+1,054.06%MGRMMonogram Orthopaedics+1.14%+4.72%+6.40%+14.16%+26.07%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGUTSFractyl Health2.3693 of 5 stars3.52.00.00.03.81.70.0ICADiCAD1.0295 of 5 stars0.05.00.00.03.00.80.0LLITLianluo SmartN/AN/AN/AN/AN/AN/AN/AN/AMGRMMonogram Orthopaedics2.9161 of 5 stars3.83.00.00.02.71.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGUTSFractyl Health 3.00Buy$11.00433.98% UpsideICADiCAD 2.00HoldN/AN/ALLITLianluo Smart 0.00N/AN/AN/AMGRMMonogram Orthopaedics 3.50Strong Buy$5.40103.01% UpsideCurrent Analyst Ratings BreakdownLatest LLIT, ICAD, GUTS, and MGRM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/17/2025ICADiCADLaidlawSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold4/16/2025ICADiCADBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral4/16/2025ICADiCADCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/15/2025GUTSFractyl HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$12.003/18/2025MGRMMonogram OrthopaedicsRoth CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$5.403/18/2025MGRMMonogram OrthopaedicsRoth MkmSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$4.00 ➝ $5.40(Data available from 6/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGUTSFractyl Health$60K1,681.54N/AN/AN/A∞ICADiCAD$19.53M5.18N/AN/A$1.27 per share2.90LLITLianluo Smart$380K54.46N/AN/A($0.59) per share-15.86MGRMMonogram Orthopaedics$365.00K260.08N/AN/A$0.43 per share6.19Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGUTSFractyl Health-$77.09M-$1.85N/AN/AN/A-64,849.48%N/A-57.21%8/13/2025 (Estimated)ICADiCAD-$4.85M-$0.19N/A∞N/A-17.81%-15.65%-12.52%8/14/2025 (Estimated)LLITLianluo Smart-$4.45MN/A0.00∞N/AN/AN/AN/AN/AMGRMMonogram Orthopaedics-$13.74M-$0.45N/AN/AN/AN/A-130.90%-106.38%8/13/2025 (Estimated)Latest LLIT, ICAD, GUTS, and MGRM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025MGRMMonogram Orthopaedics-$0.12-$0.10+$0.02-$0.10N/AN/A5/13/2025Q1 2025GUTSFractyl Health-$0.49-$0.49N/A-$0.49N/AN/A5/13/2025Q1 2025ICADiCAD-$0.0625-$0.02+$0.0425-$0.03$4.54 million$4.87 million3/19/2025Q4 2024ICADiCAD-$0.0525-$0.03+$0.0225-$0.03$4.72 million$5.41 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGUTSFractyl HealthN/AN/AN/AN/AN/AICADiCADN/AN/AN/AN/AN/ALLITLianluo SmartN/AN/AN/AN/AN/AMGRMMonogram OrthopaedicsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGUTSFractyl Health0.605.585.57ICADiCADN/A4.023.91LLITLianluo SmartN/A2.422.17MGRMMonogram OrthopaedicsN/A7.317.31Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGUTSFractyl HealthN/AICADiCAD24.61%LLITLianluo Smart28.75%MGRMMonogram Orthopaedics0.45%Insider OwnershipCompanyInsider OwnershipGUTSFractyl HealthN/AICADiCAD10.29%LLITLianluo Smart22.90%MGRMMonogram Orthopaedics28.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGUTSFractyl Health10248.98 millionN/AN/AICADiCAD14027.47 million23.81 millionOptionableLLITLianluo Smart62.21 millionN/ANot OptionableMGRMMonogram Orthopaedics2835.69 million24.67 millionNot OptionableLLIT, ICAD, GUTS, and MGRM HeadlinesRecent News About These CompaniesMonogram Orthopaedics, Inc. (NASDAQ:MGRM) Sees Significant Decrease in Short InterestJune 5, 2025 | marketbeat.comEarnings call transcript: Monogram Orthopaedics sees stock surge after Q1 2025 resultsMay 16, 2025 | investing.comMonogram Technologies Inc. (MGRM) Q1 2025 Earnings Call TranscriptMay 16, 2025 | seekingalpha.comMonogram Orthopaedics, Inc. (NASDAQ:MGRM) Q1 2025 Earnings Call TranscriptMay 16, 2025 | insidermonkey.comA Look Ahead: Monogram Technologies's Earnings ForecastMay 16, 2025 | benzinga.comMonogram Technologies Inc.: Monogram Technologies Reports First Quarter 2025 Financial ResultsMay 15, 2025 | finanznachrichten.deMonogram Tech Gets FDA Clearance for Total Knee Arthroplasty SystemMay 15, 2025 | marketwatch.comMonogram Technologies Reports First Quarter 2025 Financial ResultsMay 14, 2025 | globenewswire.comMonogram Technologies to Host First Quarter 2025 Results Conference Call on Wednesday, May 14, 2025 at 4:30 p.m. Eastern TimeMay 6, 2025 | accessnewswire.comCORRECTION FROM SOURCE: Monogram Technologies Receives Regulatory Approval to Start Clinical Trials in IndiaApril 29, 2025 | accessnewswire.comMonogram Technologies Granted Regulatory Approval to Import mBôs TKA System for Clinical Investigation in IndiaApril 29, 2025 | accessnewswire.comMonogram Orthopaedics Inc (MGRM) Receives a Rating Update from a Top AnalystApril 16, 2025 | markets.businessinsider.comWhy Monogram Technologies Inc.’s (MGRM) Stock Is Down 10.69%March 25, 2025 | aaii.comMGRM: Monogram Receives Clearance from the FDA on its 510(k) Submission for its mBôs TKA System.March 20, 2025 | msn.comMonogram Technologies Partners with Urvin to Launch an Exclusive, Verified Shareholder CommunityMarch 20, 2025 | accessnewswire.comMonogram Orthopaedics price target raised to $5.40 from $4 at Roth MKMMarch 18, 2025 | markets.businessinsider.comMonogram Orthopaedics announces 510(k) clearance for mBos TKA SystemMarch 17, 2025 | markets.businessinsider.comFDA clears robotic knee surgery system from Monogram TechnologiesMarch 17, 2025 | massdevice.comMonogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA SystemMarch 17, 2025 | accessnewswire.comAnalysts Offer Insights on Healthcare Companies: Monogram Orthopaedics Inc (MGRM) and Vivani Medical (VANI)March 13, 2025 | markets.businessinsider.comMonogram Orthopaedics, Inc. (NASDAQ:MGRM) Q4 2024 Earnings Call TranscriptMarch 13, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeLLIT, ICAD, GUTS, and MGRM Company DescriptionsFractyl Health NASDAQ:GUTS$2.06 -0.11 (-5.07%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$2.11 +0.05 (+2.43%) As of 06/13/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.iCAD NASDAQ:ICAD$3.68 -0.08 (-2.13%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$3.70 +0.02 (+0.54%) As of 06/13/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.Lianluo Smart NASDAQ:LLITLianluo Smart Limited, together with its subsidiaries, designs, develops, markets, and distributes medical products primarily in China and internationally. The company offers medical devices, including wearable sleep respiratory solutions, general hospital products, medical compressors, and related supporting products. It also provides technical services in relation to the detection and analysis of obstructive sleep apnea syndrome to hospitals and medical centers through medical wearable devices. In addition, the company distributes medical products, such as sleep apnea machines. Lianluo Smart Limited sells its products primarily through distributors; and directly to hospitals, physical examination centers, and sleep centers, as well as to individual consumers. The company was formerly known as Dehaier Medical Systems Limited and changed its name to Lianluo Smart Limited in November 2016. Lianluo Smart Limited was incorporated in 2003 and is headquartered in Beijing, China.Monogram Orthopaedics NASDAQ:MGRM$2.66 +0.03 (+1.14%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$2.66 +0.00 (+0.19%) As of 06/13/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
